NCT07580053Active, not recruiting
Hereditary Influences on Pulmonary Fibrosis Trajectories
An Observational, Prospective, Multicenter Study on Hereditary Influences on Pulmonary Fibrosis Trajectories
Source: ClinicalTrials.gov · Last updated 12 May 2026
Brief summary (registry, in English)
The SHIFT (Hereditary Influences on Pulmonary Fibrosis Trajectories) study is a prospective, multicenter, observational cohort study designed to investigate familial pulmonary fibrosis (FPF) within the Italian population.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 250 (estimated)
- First submitted
- 20 Apr 2026
- Start date
- 1 Apr 2026
- Primary completion date
- 31 Dec 2034
- Lead sponsor
- Istituto Clinico Humanitas
- Diseases
- Idiopathic pulmonary fibrosis
- NCT number
- NCT07580053
What you commit to
- Study type: Observational
- Planned participants: 250
- From 1 Apr 2026 to the primary completion date, 31 Dec 2034
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients unable to perform pulmonary function tests
Who the study is looking for
- A HRCT scan consistent with ILD diagnosis
- Age over 18 years old
- A genetic test proved variant or a polymorphism consistent with a diagnosis of FPF
- Ability to give informed consent for the inclusion in the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Francesco Amati Coordinator of this site? Confirm its status | Rozzano | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.